SE432526B - Immunogent konjugat av koriongonandotropinfragment och stelkrampstoxid som konceptionsforhindrande medel, jemte forfarande for dess framstellning - Google Patents

Immunogent konjugat av koriongonandotropinfragment och stelkrampstoxid som konceptionsforhindrande medel, jemte forfarande for dess framstellning

Info

Publication number
SE432526B
SE432526B SE7505411A SE7505411A SE432526B SE 432526 B SE432526 B SE 432526B SE 7505411 A SE7505411 A SE 7505411A SE 7505411 A SE7505411 A SE 7505411A SE 432526 B SE432526 B SE 432526B
Authority
SE
Sweden
Prior art keywords
immunogent
gonandotropragrain
toxide
chorion
conjugated
Prior art date
Application number
SE7505411A
Other languages
English (en)
Swedish (sv)
Other versions
SE7505411L (sv
Inventor
G P Talwar
Original Assignee
All India Inst Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by All India Inst Med filed Critical All India Inst Med
Publication of SE7505411L publication Critical patent/SE7505411L/xx
Publication of SE432526B publication Critical patent/SE432526B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
SE7505411A 1975-01-28 1975-05-12 Immunogent konjugat av koriongonandotropinfragment och stelkrampstoxid som konceptionsforhindrande medel, jemte forfarande for dess framstellning SE432526B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54467775A 1975-01-28 1975-01-28

Publications (2)

Publication Number Publication Date
SE7505411L SE7505411L (sv) 1976-07-29
SE432526B true SE432526B (sv) 1984-04-09

Family

ID=24173127

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7505411A SE432526B (sv) 1975-01-28 1975-05-12 Immunogent konjugat av koriongonandotropinfragment och stelkrampstoxid som konceptionsforhindrande medel, jemte forfarande for dess framstellning
SE7807571A SE432706B (sv) 1975-01-28 1978-07-05 Konceptionsforhindrande medel i form av ett immunogent konjugat av en berare och nitroderivatet av beta-hcg jemte forfarande for dess framstellning

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7807571A SE432706B (sv) 1975-01-28 1978-07-05 Konceptionsforhindrande medel i form av ett immunogent konjugat av en berare och nitroderivatet av beta-hcg jemte forfarande for dess framstellning

Country Status (11)

Country Link
US (1) US4161519A (xx)
AR (1) AR217615A1 (xx)
CA (1) CA1054937A (xx)
CH (1) CH614626A5 (xx)
DE (1) DE2518546A1 (xx)
DK (1) DK145283C (xx)
FI (1) FI54997C (xx)
IL (1) IL47177A (xx)
NL (1) NL7505412A (xx)
NO (1) NO145083C (xx)
SE (2) SE432526B (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302386A (en) * 1978-08-25 1981-11-24 The Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US6096318A (en) * 1973-05-07 2000-08-01 The Ohio State University Antigenically modified HCG polypeptides
US5698201A (en) * 1973-05-07 1997-12-16 The Ohio State University Method for treatment of antigenically modified polypeptides
US6146633A (en) * 1973-05-07 2000-11-14 The Ohio State University Method for treatment of antigenically modified polypeptides
US5006334A (en) * 1973-05-07 1991-04-09 The Ohio State University Antigenic modification of polypeptides
US4691006A (en) * 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
US6143305A (en) * 1973-05-07 2000-11-07 The Ohio State University Antigenically modified polypeptides composition
US4767842A (en) * 1973-05-07 1988-08-30 The Ohio State University Antigenic modification of polypeptides
US4762913A (en) * 1973-05-07 1988-08-09 The Ohio State University Antigenic modification of polypeptides
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4313871A (en) * 1978-02-06 1982-02-02 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4268435A (en) * 1979-02-06 1981-05-19 Research Corporation Chorionic gonadotropin derived antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4376765A (en) * 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
US4749570A (en) * 1981-12-31 1988-06-07 The Governors Of The University Of Alberta Targeting conjugates of albumin and therapeutic agents
US4966888A (en) * 1985-07-08 1990-10-30 Cornell Research Foundation, Inc. hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine
US4556555A (en) * 1985-01-25 1985-12-03 North Carolina State University Process for the immunological neutering of animals
US4722889A (en) * 1985-04-02 1988-02-02 Leeco Diagnostics, Inc. Immunoassays using multiple monoclonal antibodies and scavenger antibodies
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides
US5817753A (en) 1985-12-04 1998-10-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
US4855285A (en) * 1985-12-04 1989-08-08 The Ohio State University Research Foundation Antigenic modification of polypeptides
US5762931A (en) * 1992-12-31 1998-06-09 National Institute Of Immunology Anti-cancer utility of HCG vaccines
WO1996015807A1 (en) * 1994-11-21 1996-05-30 Scofield Virginia L Sperm as vaccine vectors
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US6716428B1 (en) 1999-10-06 2004-04-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
US20030185845A1 (en) * 2001-11-16 2003-10-02 Steen Klysner Novel immunogenic mimetics of multimer proteins
HUP0402155A2 (hu) * 2001-11-16 2005-01-28 Pharmexa A/S Multimer fehérjék új immunogén mimetikumai széleskörű T-sejt-epitóp-inszertekkel
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
MXPA05005051A (es) 2002-11-12 2006-03-10 Albert B Deisseroth Vacuna de vector adenoviral.
EA008254B1 (ru) 2003-05-09 2007-04-27 Фармекса А/С Детоксифицированный tnf и способ получения
EP1687334B1 (en) 2003-11-24 2014-01-08 MicroVAX, LLC Mucin antigen vaccine
US8828957B2 (en) * 2003-12-11 2014-09-09 Microvax, Llc Methods for generating immunity to antigen
WO2006130525A2 (en) * 2005-05-31 2006-12-07 Sidney Kimmel Cancer Center Methods for immunotherapy of cancer
AU2006311752A1 (en) * 2005-11-07 2007-05-18 Sidney Kimmel Cancer Center CD40 ligand fusion protein vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622426A5 (en) * 1973-05-07 1981-04-15 Univ Ohio Contraceptive composition

Also Published As

Publication number Publication date
NO145083B (no) 1981-10-05
DE2518546A1 (de) 1976-07-29
DK206975A (da) 1976-07-29
FI54997B (fi) 1979-01-31
SE7807571L (sv) 1978-07-05
FI54997C (fi) 1979-05-10
NL7505412A (nl) 1976-07-30
IL47177A0 (en) 1975-06-25
SE7505411L (sv) 1976-07-29
US4161519A (en) 1979-07-17
AR217615A1 (es) 1980-04-15
CH614626A5 (xx) 1979-12-14
SE432706B (sv) 1984-04-16
NO751680L (xx) 1976-07-29
DK145283B (da) 1982-10-25
NO145083C (no) 1982-01-27
IL47177A (en) 1979-01-31
CA1054937A (en) 1979-05-22
DK145283C (da) 1983-05-16
FI751746A (xx) 1976-07-29

Similar Documents

Publication Publication Date Title
SE432526B (sv) Immunogent konjugat av koriongonandotropinfragment och stelkrampstoxid som konceptionsforhindrande medel, jemte forfarande for dess framstellning
NO146909C (no) Fremgangsmaate til fremstilling av terapeutisk virksomme pyrrolidinderivater.
AT346126B (de) Insektizides mittel
FR2432511B1 (fr) Derives triazoliques, leur preparation et leur application en tant que medicaments
SE7611879L (sv) (1-fenyl-2-triazolyl-etyl)-eterderivat, sett for deras framstellning och deras anvendnig som fungicider
SE434946B (sv) Forfarande for framstellning av acylsackariner och acyl-3-oxo-1,2-densisotiazoliner
SE431501B (sv) Lagskummande desinfektionsmedelskomposition for spray- och besprutningsforfarande
AT346649B (de) Insektizides mittel
AT346646B (de) Insektizides mittel
NO143747C (no) Carboxyalkylestere av n-fosfonmethylglycin for anvendelse som herbicide midler
AU513672B2 (en) Reducing loss of water by transpiration and composition therefor
FI793688A (fi) Hydroxipropyl-triazol foerfarande foer framstaellning av dem och deras anvaendning som laekemedel
SE426953B (sv) Forfarande for framstellning av flytande och lagringsbestendiga organopolysiloxankompositioner
BR7602192A (pt) Composicoes de ftalocianina,estabilizadas contra cristalizacao e transformacao da modificacao
SE7900792L (sv) 2h-bensofuran-3-on-derivat och forfarande for framstellning av dem
AR210243A1 (es) Nuevos derivados de 2,3-dihidro-3,3-dimetil-benzofuran-5-il-amino-sulfonatos,los correspondientes 2-morfolin-y2-piperidin-benzofuran-5-il-aminosulfonatos y composiciones herbicidas que los contienen
SE7608100L (sv) 2'-3,-6'-triklor-4-cyano-4'-bensoylureido-difenyletrar till anvendning som insekticider och sett for deras framstellning
SE7611880L (sv) ]-(2-halogen-2-fenyl-etyl)-triazoler, sett for deras framstellning och deras anvendning som fungicider
SE435290B (sv) Forfarande for framstellning av gamma-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-(2-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat
DK63990D0 (da) 7-aminocephalosporinderivater til anvendelse som mellemprodukt til fremstilling af sephalosporinderivater
OA06084A (fr) Nouveaux dérivés de 2-imino-imidazolidine, leur préparation et leur application en tant que médicaments.
IT1109545B (it) Derivati di n-fenil-1,3-ossazolidin-2,4-dionifungicidi e procedimento di preparazione
IT7920786A0 (it) Derivati della n-fenil-alanina, loro preparazione e loro impiegocome prodotti medicinali.
SE411670B (sv) 2-klor-n-isopropyl-2',3'-dimetylacetanilid till anvendning som herbicidalt medel och forfarande for dess framstellning
SE7613946L (sv) Sekundera eteraminacetat och deras anvendning som preparationsmedel for syntetfibrer

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7505411-4

Effective date: 19910123

Format of ref document f/p: F